Clinical Application of Blood Product Irradiation for Hematological Purpose-Review.
10.7534/j.issn.1009-2137.2019.06.053
- Author:
Qing-Sheng CAO
1
;
Ming-Hui WANG
2
Author Information
1. Departwent of Blood Component,Beijing Red Cross Blood Service Center, Beijing 100088, China.
2. Departwent of Blood Component,Beijing Red Cross Blood Service Center, Beijing 100088, China,E-mail@magi11909@vip.sina.com.
- Publication Type:Journal Article
- MeSH:
Blood Transfusion;
China;
Gamma Rays;
Graft vs Host Disease;
Humans
- From:
Journal of Experimental Hematology
2019;27(6):2030-2034
- CountryChina
- Language:Chinese
-
Abstract:
Abstract With the development of transfusion medicine and the mastery of blood transfusion diagnosis and treatment techniques, the application of irradiated blood products in our country is gradually increasing. In recent years, the proportion of blood transfused by γ-rays has been increasing. In some foreign countries, the application rate of blood irradiated by radiotherapy is as high as 95%. At present, it is still in the promotion stage in China. This article summarizes the commonly used methods of blood irradiation, including the choice of irradiation source, the core dose and common irradiation targets, compares the difference of different irradiation methods, and generalizes the common application of blood irradiation. It is proposed that in addition to TA-GVHD application, blood irradiation may have a broad prospects for cancer therapy and microbial killing.
